active pharmaceutical ingredients (APIs) | chemanager-online.com - Chemistry and Life Science

Apr. 20, 2020
Topics
Chemical Process Research and Development
Increasing demands for outsourced solutions has made contract research organizations (CROs) an important facet of the pharmaceutical landscape. Innovator pharma will regularly approach such organizations in order to meet their growing ...
Apr. 20, 2020
Topics
Nanoforming
In 2019, the pharmaceutical industry invested $182 billion in drug development, but only 48 drugs were approved for use. Last year was no deviation from the norm; the great expense and low success rates associated with drug development ...
Apr. 08, 2020
News & Opinions
AGC Expands Spanish Facilities
AGC Pharma Chemicals Europe, part of Japanese group AGC (formerly known as Asahi Glass Chemical), plans to expand its facilities in Barcelona, Spain, in order to meet accelerating demand.
Apr. 08, 2020
News & Opinions
FDA Says Pandemic Hasn’t Hit China’s Drug Exports
In early March, the Indian government asserted that the coronavirus epidemic in China was affecting its supply of active pharmaceutical ingredients (APIs), on which it relies for 70% of the generic drugs it makes. This could affect global ...
Mar. 24, 2016
News & Opinions
Ardian in Talks for Sale of Novacap Stake
French private equity fund Ardian has started talks with two buy-out firms for the sale of its majority stake in chemicals and pharmaceuticals producer Novacap. ...
Mar. 15, 2016
News & Opinions
Dottikon Boosts Swiss API Capacities
Swiss fine chemical company Dottikon is investing more than 100 million Swiss francs ($101 million) at its site in Aargau to add chemical process development and production capacities for active pharmaceutical ingredients (APIs). ...
Mar. 02, 2016
News & Opinions
US Law Firm Probes Dr. Reddy’s and PTC
US law firm Zeldes Haeggquist & Eck has started investigating a possible violation of federal securities laws by Indian generics manufacturer Dr. Reddy’s Laboratories and US biopharmaceutical company PTC Therapeutics. ...
Dec. 04, 2015
News & Opinions
IMCD Buys Brazil’s SelectChemie, Opens Lab
Dutch distribution company IMCD has agreed to buy Brazilian pharmaceutical distributor Selectchemie. The portfolio of the Sao Paulo-based company with 43 employees and revenues of $18 million in 2014 includes an extensive range of ...
Sep. 25, 2015
News & Opinions
Siegfried Ready to Take Over BASF Sites
Siegfried Holding, the Swiss drug contract manufacturer, said it has completed all closing conditions for its acquisition of the custom synthesis business of BASF and parts of the German group’s current active pharmaceutical ...
Sep. 17, 2015
News & Opinions
Johnson Matthey Realigns Fine Chemicals
As part of a customer-focused initiative to unite its diverse fine chemicals capabilities, Johnson Matthey, a US company best known internationally for catalyst manufacture, has realigned the business, creating four key platforms: Custom ...

12

Register now!

The latest information directly via newsletter.

GIT Verlag